EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC30A1, SLC30A5, and SLC30A9 transporters play crucial role in ligand-independent activation of ESR1 signalling in breast cancer cells via modulation of AKT activity by zinc

Szymon Lekki-Porębski iD, Michał Rakowski, Agnieszka Grzelak

Metallomics · 31.01.2026 · 18 (1)

DOI: 10.1093/mtomcs/mfag011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metallomics, online erschienen am 06.03.2026. Verfasst von Szymon Lekki-Porębski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Digital Biology and Biomedical Science - Biobank Lodz, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, P…. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Breast Neoplasms, Zinc, Signal Transduction. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zinc is essential for cellular homeostasis and acts both as a structural element and a secondary messenger in intracellular signalling. While the role of SLC39 (former ZIP) family transporters in breast cancer biology is intensively studied, the signalling function of SLC30 family transporters (former ZnT) remains insufficiently explored. This study investigates the involvement of SLC30 transporters in oestrogen receptor-positive (ER+) breast cancer. Bioinformatic and experimental analyses revealed that SLC30 transporters, particularly SLC30A1, SLC30A5, and SLC30A9, regulate the PTP/AKT/ESR1 pathway, contributing to hormone-independent ESR1 activation. Zn-dependent inhibition of PTP phosphatases modulates kinase signalling, promoting proliferation. Notably, high SLC30 expression correlates with improved survival, but serves as a negative prognostic marker under tamoxifen treatment. Here, we evidence that ESR1 directly represses SLC30 transcription and that zinc transporters form a regulatory feedback loop sustaining ER+ breast tumour progression. These findings position SLC30 transporters as active participants in signalling cascades, offering novel targets for therapeutic intervention in ER+ breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Receptor alphaBreast NeoplasmsZincSignal TransductionProto-Oncogene Proteins c-aktCation Transport ProteinsHumansFemaleGene Expression Regulation, NeoplasticCell Line, TumorLigands

Substanzen

Estrogen Receptor alphaZincProto-Oncogene Proteins c-aktESR1 protein, humanCation Transport ProteinsLigands

Autor:innen und Institutionen

  • Centre for Digital Biology and Biomedical Science - Biobank Lodz, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland.
  • The Bio-Med-Chem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, University of Lodz, 90-237 Lodz, Poland.

ORCID-Profile: Szymon Lekki-Porębski

Zitieren

APA

Lekki-Porębski, S., Rakowski, M., & Grzelak, A. (2026). SLC30A1, SLC30A5, and SLC30A9 transporters play crucial role in ligand-independent activation of ESR1 signalling in breast cancer cells via modulation of AKT activity by zinc. Metallomics, 18(1). https://doi.org/10.1093/mtomcs/mfag011

Vancouver

Lekki-Porębski S, Rakowski M, Grzelak A. SLC30A1, SLC30A5, and SLC30A9 transporters play crucial role in ligand-independent activation of ESR1 signalling in breast cancer cells via modulation of AKT activity by zinc. Metallomics. 2026;18(1). doi:10.1093/mtomcs/mfag011

BibTeX
@article{LekkiPorbski2026,
  author = {Lekki-Porębski, Szymon and Rakowski, Michał and Grzelak, Agnieszka},
  title = {SLC30A1, SLC30A5, and SLC30A9 transporters play crucial role in ligand-independent activation of ESR1 signalling in breast cancer cells via modulation of AKT activity by zinc},
  journal = {Metallomics},
  year = {2026},
  volume = {18},
  number = {1},
  doi = {10.1093/mtomcs/mfag011}
}
Kostenlos starten →